乳制品和心肌梗塞后功能下降:阿尔法欧米茄队列中的前性分析
Anniek C van Westing1, Esther Cruijsen1, Trudy Voortman2
1Division of Human Nutrition and Health, Wageningen University & Research, the Netherlands.
Clinical nutrition (Edinburgh, Scotland)
|June 12, 2023
概括
包括牛奶,奶酪和甜点在内的乳制品摄入量没有影响心肌梗塞后患者的功能下降. 酸奶摄入量显示出潜在的不良关联,需要进一步调查.
科学领域:
- 心血管健康 心血管健康
- 腎臟病學 (nephrology) 是一種醫學.
- 营养流行病学 营养流行病学
背景情况:
- 之前的研究表明,乳制品和脏功能的结果各不相同.
- 心肌梗塞 (MI) 后患者是潜在的脏健康问题的一个特定人群.
研究的目的:
- 检查乳制品消费与功能下降之间的关联.
- 专注于心脏病发作后接受药物治疗的患者.
主要方法:
- 对来自阿尔法-欧米茄队列的2169名心脏病后患者的分析.
- 通过食物频率调查问卷收集的饮食数据.
- 估计的淋巴膜过率 (eGFR) 变化,用CKD-EPI方程计算40个月的时间.
主要成果:
- 牛奶,奶酪和乳制品甜点的高摄入量与功能下降没有关联.
- 酸奶的高摄入量与每年的eGFR变化有不利关联 (β: -0.50 [-0.91;-0.09]).
- 对酸奶的分片分析没有显示出明确的剂量反应关系.
结论:
- 牛奶,奶酪和乳制品甜点似乎没有影响MI后功能下降.
- 与酸奶的不良关联需要谨慎解释和进一步验证.
- 这些发现需要在其他冠状动脉心脏病患者队列中得到确认.
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
11
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
11
Acute Kidney Injury IV: Diagnostic Studies and Prevention
40
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
40
Myocarditis IV: Nursing Management
13
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Atherosclerosis III: Management
15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
127
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
204
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
204


